Welcome My Account Log off Log In / Register
Toggle navigation      
  • Log In / Register
  • Welcome
  • My AccountLog off
  • Home
  • Product Information  
    • Baraclude® (entecavir monohydrate)
    • Eliquis® (apixaban)
    • Empliciti®▼(elotuzumab)
    • Evotaz® (atazanavir sulphate and cobicistat)
    • Nulojix® (belatacept)
    • Opdivo® (nivolumab)
    • Orencia® (abatacept)
    • Reyataz® (atazanavir)
    • Sprycel® (dasatinib)
    • Sustiva® (efavirenz)
    • Yervoy® (ipilimumab)
    • Zerit® (stavudine)
  • Submit Medical Enquiry
  • Contact Us
 
 
 

Site Map

Products and Prescribing Information

  • Baraclude® (entecavir monohydrate)
  • Eliquis® (apixaban)
  • Empliciti®▼ (elotuzumab)
  • Evotaz® (atazanavir sulphate and cobicistat)
  • Nulojix® (belatacept)
  • Opdivo® (nivolumab)
  • Orencia® (abatacept)
  • Reyataz® (atazanavir)
  • Sprycel® (dasatinib)
  • Sustiva® (efavirenz)
  • Yervoy® (ipilimumab)
  • Zerit® (stavudine)

Contact Us

  • Medical Information Enquiries

General Site

  • Home
  • Privacy Policy
  • Legal Notice

Log in / Registration

  • Log in / Register

My account

  • My account

▼ This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard or by searching for MHRA Yellow Card in the Google Play or Apple App Store. Adverse reactions should also be reported to Bristol-Myers Squibb Medical Information on 0800 731 1736 or medical.information@bms.com

You may contact our EU Data Protection Officer at EUDPO@BMS.com to exercise any data privacy rights that you may have, as well as to raise any concerns or questions in relation to the handling of your personal data by Bristol-Myers Squibb Company.

  • Privacy Policy
  • Legal Notice
  • Site Map
  • Worldwide Medical Information Portal

Your use of this information is subject to the terms and conditions of our Legal Notice and Privacy Policy. This site is intended for healthcare partners and is for informational purposes only.

Your use of this information is subject to the terms and conditions of our Legal Notice and Privacy Policy. This site is intended for healthcare partners and is for informational purposes only.

Bristol-Myers Squibb Pharmaceuticals Limited
Registered Office: Uxbridge Business
Park, Sanderson Road, Uxbridge,
Middlesex, UB8 1DH
© 2020 Bristol-Myers Squibb Company
NOUK2000446-01 05/20

You are now leaving the Bristol-Myers Squibb Medical Information Online U.K. website.
Do you wish to continue?

ContinueCancel

This website is best viewed using the horizontal display on your tablet device.

This website is best viewed using the vertical display on your mobile device.

Welcome to Bristol-Myers Squibb
Medical Information

Celgene is now part of Bristol Myers Squibb. For heritage Celgene product medical information enquiries or to report an adverse event please call 0800-731-1736 or
submit an online request.

For all other product medical information inquiries please continue to the website.

NOUK2000807-01 08/20